New York, May 5 Pfizer is discussing expedited approval of its Covid-19 vaccine with the Indian government, company CEO Alber Bourla said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic. “We are currently discussing
Hyderabad, April 30 Bharat Biotech on Thursday announced that it is slashing the price of its Covid-19 vaccine Covaxin to Rs 400, from Rs 600 earlier, for state governments. The announcement came a day after the Serum Institute of India
Hyderabad, April 25 Bharat Biotech’s pricing announcement of its Covid-19 vaccine, Covaxin on Saturday is likely to further intensify the debate on pricing as the critics have slammed both the vaccine manufacturers for ‘profiteering’. However, Bharat Biotech, like Serum Institute
New Delhi, April 17 The cumulative number of Covid-19 vaccine doses administered in the country touched 12 crore on Saturday as part of the world’s largest inoculation drive with over 30 lakh doses administered in the last 24 hours, as
New Delhi, April 8 Prime Minister Narendra Modi on Thursday received the second dose of Covid-19 vaccine here at the city’s premier All India Institute of Medical Sciences (AIIMS), giving a message to the people that “vaccination is among the
Lucknow, April 5 Uttar Pradesh Chief Minister Yogi Adityanath received the first dose of a Covid-19 vaccine on Monday at the Civil Hospital here. Yogi was administered the jab by staff nurse Rashmi Singh. The Chief Minister later said that
New Delhi, March 16 The Indian government has supplied as many as 70 nations with over 58 million doses of Covid-19 vaccines so far, parliament was informed on Tuesday. In a reply to a question in the Rajya Sabha, Minister
New Delhi, March 12 Industry body FICCI has urged the government to include the retail industry in the list of ‘frontline workers’ and among the early recipients of the Covid-19 vaccine. In a letter written to health minister Harsh Vardhan,
New York, Jan 26 US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in the UK and South Africa. Vaccination with the Moderna Covid-19 Vaccine produced neutralising titers against all key emerging
Dhaka, Jan 20 Bangladesh Health Minister Zahid Maleque has said that the country would receive two million doses of the AstraZeneca Covid-19 vaccine (Covishield) from India as a “gift” on Wednesday. Maleque confirmed to IANS that a special Air India
New Delhi, Jan 6 A dry run for the Covid vaccine will be conducted at 8 sites in the national capital on Wednesday, officials said. The dry run will be held at two hospitals under the North Delhi Municipal Corporation
Geneva, Jan 6 The World Health Organisation (WHO) on Tuesday said that Covid-19 patients should be given two doses of the Pfizer/BioNTech vaccine within a period of 21-28 days. Alejandro Cravioto, chairman of WHO’s Strategic Advisory Group of Experts on
New Delhi, Dec 29 Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine – Covishield receiving the regulatory approval in “few days”, while emphasising that the company has a massive stockpile 40-50 million doses.
New Delhi, Dec 21 Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest,
New Delhi, Dec 20 Union Health Minister Harsh Vardhan on Saturday announced that India is at the cusp of authorizing the first set of Covid-19 vaccines and expressed the need for an expeditious vaccination drive to cover all the target
New Delhi, Dec 19 India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, said in an interview with Rossiya 24 TV channel. “In
Moscow, Dec 18 India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel. “In India,
New Delhi, Dec 8 (IANS) Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by
Chandigarh, Dec 2 With the Covid-19 vaccine in the final stages of operationalisation in India, Chief Minister Amarinder Singh on Wednesday said he will take the first shot of the vaccine in Punjab, once it is cleared by the Indian
Chennai, Dec 1 Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe. The company also said the serious adverse event (SAE) that happened
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
|
